Format

Send to

Choose Destination
Fertil Steril. 2018 Nov;110(6):994-1002. doi: 10.1016/j.fertnstert.2018.09.020.

Innovations in assisted reproductive technologies: impact on contemporary donor egg practice and future advances.

Author information

1
Department of Gynecology and Obstetrics, Division of Reproductive Endocrinology, Johns Hopkins University School of Medicine, Lutherville, Maryland. Electronic address: mchris21@jhmi.edu.
2
Instituto Valenciano de Infertilidad and Department of Pediatrics, Obstetrics, and Gynecology, School of Medicine, Valencia University, Valencia, Spain.

Abstract

Innovations in assisted reproductive technologies (ART) have driven progress in the donor egg field since the birth of the first baby derived from a donor egg in 1983. Over time, donor oocytes have become an increasingly used option for patients unable to conceive with autologous oocytes. In donor egg, the unique separation of the oocyte source and recipient uterus has created a model that has propelled advances in ART. Progressive ART innovations that have optimized the oocyte donor and resulting embryo include the following: evaluation of ovarian reserve, controlled ovarian hyperstimulation regimens that reduce the risk of ovarian hyperstimulation syndrome, blastocyst culture, oocyte cryopreservation, and preimplantation genetic testing. For donor egg recipients, methods to optimize the endometrium to maximize implantation include endometrial receptivity testing, immunologic donor-recipient matching, and increased understanding of the uterine microbiome.

KEYWORDS:

Oocyte donation; assisted reproductive technology; donor egg

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center